abstract |
(57) [Summary]nThe present invention relates to certain 2-indolinone compounds that modulate the activity of protein kinases ("PK") and phosphatases. Accordingly, the compounds of the present invention are useful for treating diseases associated with abnormal PK activity. Also disclosed are pharmaceutical compositions containing these compounds, methods of treating diseases with the pharmaceutical compositions containing these compounds, and methods of making them. |